Regeneron Pharmaceuticals | REGN - Interest Income


Regeneron Pharmaceuticals reported $193.3M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
AbbVie USD 59M 13M Dec/2025
Agios Pharmaceuticals USD 12.41M 959K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Astellas Pharma JPY 4.12B 2.94B Mar/2024
AstraZeneca USD 73M 62M Mar/2026
Biogen USD 37.9M 700K Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Gilead Sciences USD 95M 7M Dec/2025
GlaxoSmithKline GBP 22M 96M Mar/2026
Incyte USD 33.69M 2.93M Mar/2026
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
J&J USD 2.14 237M Mar/2026
Kyowa Hakko Kirin JPY 2.54B 1.52B Jun/2024
Merck USD 69M 27M Dec/2025
Moderna USD 70M 3M Dec/2025
Pfizer USD 115M 51M Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Sanofi EUR 114M 38M Sep/2025
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025
Vertex Pharmaceuticals USD 114.8M 7.1M Mar/2026